Skip to content
Clinical Trials – home

Ophtalmologie Maison Rouge S.C.M.

Research site

France 6 Rue De L Eglise, 67000 STRASBOURG, Alsace, France

  • Dry age-related macular degeneration · Retinal vein occlusion · Choroidal neovascularisation
  • Adult patients

About Specializations

Ophtalmologie Maison Rouge S.C.M. in STRASBOURG, Alsace, France specialises in clinical trials of conditions such as Dry age-related macular degeneration, Retinal vein occlusion, Choroidal neovascularisation, Macular oedema, and other specialisations. This site conducts important research.

Main research areas of the site

Eye Diseases

At Ophtalmologie Maison Rouge S.C.M. in Strasbourg, the clinical research program focuses on ophthalmology and a narrow but important range of eye diseases. The studies are centered on improving vision care for conditions that can cause major loss of sight, including age-related macular degeneration, geographic atrophy, retinal vein occlusion, and pathologic myopia.

  • Research on treatments for macular edema and central retinal vein occlusion aims to improve visual outcomes and reduce retinal swelling.
  • Studies in geographic atrophy and dry AMD are evaluating new approaches to preserve vision and slow disease progression.
  • Trials in choroidal neovascularization linked to pathologic myopia are testing therapies designed to control abnormal blood vessel growth and protect sight.

Overall, the site is contributing to clinical research that compares treatment effectiveness, examines safety, and seeks better ways to maintain visual function in patients with chronic retinal conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
6 Rue De L Eglise67000 STRASBOURG, AlsaceFrance
Recruiting now
no trials
Conditions studied
5

More sites in STRASBOURG, AlsaceFrance

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

A Phase 2 Study of Aganirsen Eye Drops to Extend Intravitreal Aflibercept Injection Interval in Patients with Wet Age‑Related Macular Degeneration

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept

Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:ANX007
  • Sponsor:Annexon Inc.

Study on Long-Term Safety and Effects of Pegcetacoplan for Patients with Geographic Atrophy from Age-Related Macular Degeneration

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pegcetacoplan
  • Sponsor:Apellis Pharmaceuticals Inc.

Study on the Effect of Aflibercept Injections in Patients with Central Retinal Vein Occlusion (CRVO) and Spontaneous Retinal Arterial Pulsations (SRAPs)

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Fondation A De Rothschild

Macular oedema+1

Not recruiting

Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Bayer AG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.